TYRA Earnings Date: Nov 4, 2026 (Estimated) — Tyra Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is TYRA's next earnings date?
Tyra Biosciences, Inc. (TYRA) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.67.
How did TYRA do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Tyra Biosciences, Inc. posted EPS of -$0.69 versus the -$0.65 estimate, a miss of 6.2%. Revenue was $0. The stock's 1-day post-earnings move was -21.0%.
How much does TYRA stock move after earnings?
TYRA beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.2% (up or down) in the day after earnings.
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | -0.65 | -0.69 | -6.15% | $0 | ❌ Miss | -20.97% | -22.59% | -22.75% |
| 2026-05-13 | Q1 2026 | -0.59 | -0.64 | -8.47% | $0 | ❌ Miss | +3.79% | -3.13% | -26.67% |
| 2026-03-02 | Q4 2025 | -0.53 | -0.57 | -7.55% | $0 | ❌ Miss | +1.51% | +3.78% | +17.77% |
| 2025-11-05 | Q3 2025 | -0.51 | -0.50 | +1.96% | $0 | ✅ Beat | -3.64% | +4.45% | +45.07% |
| 2025-08-14 | Q2 2025 | -0.52 | -0.47 | +9.62% | $0 | ✅ Beat | +0.28% | +9.35% | +15.05% |
| 2025-03-27 | Q4 2024 | -0.46 | -0.43 | +6.52% | $0 | ✅ Beat | +1.14% | -14.08% | +7.04% |
| 2024-11-07 | Q3 2024 | -0.40 | -0.41 | -2.50% | $0 | ❌ Miss | -6.06% | -4.72% | -6.71% |
| 2024-08-07 | Q2 2024 | -0.41 | -0.32 | +21.95% | $0 | ✅ Beat | +4.31% | +10.62% | +5.59% |
Showing last 8 quarters.